ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,281,496 shares; 2026Q3: 10,281,496 shares 10,281,496 $2.34B 23.5% 0 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 28,933,371 shares; 2026Q3: 29,177,964 shares 29,177,964 $942M 9.45% +244,593 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,689,190 shares; 2025Q1: 12,189,149 shares; 2025Q2: 11,965,991 shares; 2025Q3: 11,965,991 shares; 2025Q4: 10,724,599 shares; 2026Q1: 11,474,599 shares; 2026Q2: 11,474,599 shares; 2026Q3: 11,474,599 shares 11,474,599 $653M 6.55% 0 Timeline RYTM RHYTHM PHARMACEUTICALS INC More: the full row for RHYTHM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,084,412 shares; 2025Q1: 6,084,412 shares; 2025Q2: 5,561,359 shares; 2025Q3: 5,681,359 shares; 2025Q4: 6,666,837 shares; 2026Q1: 6,666,837 shares; 2026Q2: 6,666,837 shares; 2026Q3: 6,666,837 shares 6,666,837 $635M 6.37% 0 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,909,091 shares; 2025Q1: 8,909,091 shares; 2025Q2: 9,902,633 shares; 2025Q3: 10,428,437 shares; 2025Q4: 10,428,437 shares; 2026Q1: 10,428,437 shares; 2026Q2: 8,392,730 shares; 2026Q3: 8,392,730 shares 8,392,730 $341M 3.42% 0 Timeline TYRA TYRA BIOSCIENCES INC More: the full row for TYRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,637,290 shares; 2025Q1: 10,637,290 shares; 2025Q2: 12,198,625 shares; 2025Q3: 12,198,625 shares; 2025Q4: 12,198,625 shares; 2026Q1: 12,198,625 shares; 2026Q2: 12,198,625 shares; 2026Q3: 12,198,625 shares 12,198,625 $267M 2.68% 0 Timeline FRNM FREENOME INC More: the full row for FREENOME INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 15,367,270 shares 15,367,270 $242M 2.43% new Timeline COAG HEMAB THERAPEUTICS HLDGS INC More: the full row for HEMAB THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 7,808,627 shares; 2026Q3: 7,808,627 shares 7,808,627 $241M 2.42% 0 Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,845,000 shares; 2025Q1: 10,138,938 shares; 2025Q2: 10,138,938 shares; 2025Q3: 10,138,938 shares; 2025Q4: 9,550,191 shares; 2026Q1: 9,550,191 shares; 2026Q2: 9,550,191 shares; 2026Q3: 9,550,191 shares 9,550,191 $232M 2.33% 0 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,995,858 shares; 2025Q1: 6,995,858 shares; 2025Q2: 6,995,858 shares; 2025Q3: 6,995,858 shares; 2025Q4: 6,995,858 shares; 2026Q1: 6,995,858 shares; 2026Q2: 6,995,858 shares; 2026Q3: 5,502,858 shares 5,502,858 $215M 2.16% -1,493,000 Timeline SGP SPYGLASS PHARMA INC More: the full row for SPYGLASS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,021,117 shares; 2026Q2: 8,021,117 shares; 2026Q3: 8,021,117 shares 8,021,117 $209M 2.09% 0 2026-11-16, Form 4 : bought 1,000 shares on 2026-11-16 Timeline JANX JANUX THERAPEUTICS INC More: the full row for JANUX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,365,652 shares; 2025Q1: 11,189,693 shares; 2025Q2: 11,189,693 shares; 2025Q3: 11,189,693 shares; 2025Q4: 11,189,693 shares; 2026Q1: 11,189,693 shares; 2026Q2: 11,189,693 shares; 2026Q3: 11,189,693 shares 11,189,693 $193M 1.94% 0 Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,850,984 shares; 2025Q1: 6,147,280 shares; 2025Q2: 6,147,280 shares; 2025Q3: 7,323,750 shares; 2025Q4: 7,323,750 shares; 2026Q1: 7,692,750 shares; 2026Q2: 7,692,750 shares; 2026Q3: 7,692,750 shares 7,692,750 $193M 1.94% 0 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,577,106 shares; 2025Q2: 1,577,106 shares; 2025Q3: 1,577,106 shares; 2025Q4: 1,976,132 shares; 2026Q1: 2,450,221 shares; 2026Q2: 2,450,221 shares; 2026Q3: 2,450,221 shares 2,450,221 $160M 1.61% 0 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,872,503 shares; 2025Q1: 10,872,503 shares; 2025Q2: 23,555,648 shares; 2025Q3: 23,555,648 shares; 2025Q4: 23,555,648 shares; 2026Q1: 23,555,648 shares; 2026Q2: 23,555,648 shares; 2026Q3: 30,435,190 shares 30,435,190 $148M 1.49% +6,879,542 Timeline BCAX BICARA THERAPEUTICS INC More: the full row for BICARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,955,993 shares; 2025Q1: 6,955,993 shares; 2025Q2: 6,955,993 shares; 2025Q3: 6,955,993 shares; 2025Q4: 6,955,993 shares; 2026Q1: 7,255,993 shares; 2026Q2: 7,255,993 shares; 2026Q3: 7,255,993 shares 7,255,993 $135M 1.35% 0 Timeline ARTV ARTIVA BIOTHERAPEUTICS INC More: the full row for ARTIVA BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,853,302 shares; 2025Q1: 9,853,302 shares; 2025Q2: 9,853,302 shares; 2025Q3: 9,853,302 shares; 2025Q4: 9,853,302 shares; 2026Q1: 9,853,302 shares; 2026Q2: 17,955,642 shares; 2026Q3: 18,489,293 shares 18,489,293 $132M 1.32% +533,651 Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 575,000 shares; 2025Q1: 575,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,897,237 shares; 2026Q2: 5,274,274 shares; 2026Q3: 5,274,274 shares 5,274,274 $132M 1.32% 0 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,554,597 shares; 2026Q3: 1,554,597 shares 1,554,597 $129M 1.3% 0 Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,279,341 shares 4,279,341 $125M 1.25% new Timeline CLYM CLIMB BIO INC More: the full row for CLIMB BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 31,419,267 shares; 2025Q1: 31,419,267 shares; 2025Q2: 31,419,267 shares; 2025Q3: 31,419,267 shares; 2025Q4: 11,293,828 shares; 2026Q1: 11,300,939 shares; 2026Q2: 11,300,939 shares; 2026Q3: 10,130,130 shares 10,130,130 $116M 1.17% -1,170,809 2026-11-05, 13D/A : 23,941,277 shares, 33% of the class, 13D/A filed 2026-11-09 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,132,557 shares; 2026Q3: 1,030,058 shares 1,030,058 $102M 1.02% -102,499 Timeline WVE WAVE LIFE SCIENCES INC More: the full row for WAVE LIFE SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 26,975,505 shares 26,975,505 $99.8M 1% new 2026-10-05, Form 4 : granted 10,700 shares on 2026-10-05 Timeline LTGO LATIGO BIOTHERAPEUTICS INC More: the full row for LATIGO BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,302,933 shares 5,302,933 $88.6M 0.89% new Timeline SLDB SOLID BIOSCIENCES INC More: the full row for SOLID BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,330,446 shares; 2025Q1: 4,330,446 shares; 2025Q2: 5,811,323 shares; 2025Q3: 5,811,423 shares; 2025Q4: 5,811,423 shares; 2026Q1: 9,339,978 shares; 2026Q2: 12,036,126 shares; 2026Q3: 12,036,126 shares 12,036,126 $87M 0.87% 0 2026-11-04, 13D/A : 12,036,126 shares, 10.8% of the class, 13D/A filed 2026-11-06 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,982,301 shares; 2025Q4: 5,404,998 shares; 2026Q1: 5,404,998 shares; 2026Q2: 2,402,095 shares; 2026Q3: 4,503,882 shares 4,503,882 $85.9M 0.86% +2,101,787 Timeline LBRX LB PHARMACEUTICALS INC More: the full row for LB PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,776,958 shares; 2025Q4: 2,208,604 shares; 2026Q1: 2,208,604 shares; 2026Q2: 2,208,604 shares; 2026Q3: 2,208,604 shares 2,208,604 $84.8M 0.85% 0 Timeline GHRS GH RESEARCH PLC More: the full row for GH RESEARCH PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,686,689 shares; 2025Q1: 6,944,648 shares; 2025Q2: 7,676,697 shares; 2025Q3: 7,676,697 shares; 2025Q4: 7,676,697 shares; 2026Q1: 7,676,697 shares; 2026Q2: 7,636,813 shares; 2026Q3: 3,609,007 shares 3,609,007 $84.7M 0.85% -4,027,806 Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,957,103 shares 5,957,103 $81.8M 0.82% new Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,295,040 shares; 2025Q1: 1,295,040 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,707,262 shares; 2026Q2: 5,743,533 shares; 2026Q3: 2,815,543 shares 2,815,543 $74.2M 0.74% -2,927,990 Timeline FDMT 4D MOLECULAR THERAPEUTICS IN More: the full row for 4D MOLECULAR THERAPEUTICS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,563,211 shares; 2025Q1: 4,563,211 shares; 2025Q2: 4,563,211 shares; 2025Q3: 4,563,211 shares; 2025Q4: 5,653,211 shares; 2026Q1: 5,049,779 shares; 2026Q2: 5,049,779 shares; 2026Q3: 5,049,779 shares 5,049,779 $72.3M 0.72% 0 Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,666,667 shares; 2025Q1: 4,666,667 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,804,072 shares; 2026Q2: 12,723,026 shares; 2026Q3: 12,723,026 shares 12,723,026 $66.9M 0.67% 0 Timeline SANA SANA BIOTECHNOLOGY INC More: the full row for SANA BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 18,750,000 shares; 2026Q3: 18,750,000 shares 18,750,000 $54.7M 0.55% 0 Timeline MNPR MONOPAR THERAPEUTICS INC More: the full row for MONOPAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 511,207 shares; 2025Q1: 511,207 shares; 2025Q2: 511,207 shares; 2025Q3: 511,207 shares; 2025Q4: 667,207 shares; 2026Q1: 667,207 shares; 2026Q2: 667,207 shares; 2026Q3: 667,207 shares 667,207 $53.2M 0.53% 0 Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,009,536 shares; 2025Q1: 60,379,366 shares; 2025Q2: 60,379,366 shares; 2025Q3: 60,379,366 shares; 2025Q4: 63,771,366 shares; 2026Q1: 63,771,366 shares; 2026Q2: 42,809,751 shares; 2026Q3: 42,754,145 shares 42,754,145 $52.6M 0.53% -55,606 Timeline DMRA DAMORA THERAPEUTICS INC More: the full row for DAMORA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,399,702 shares 2,399,702 $51.1M 0.51% new Timeline PEPG PEPGEN INC More: the full row for PEPGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,689,545 shares; 2025Q1: 10,689,545 shares; 2025Q2: 10,689,545 shares; 2025Q3: 20,064,545 shares; 2025Q4: 20,064,545 shares; 2026Q1: 20,064,545 shares; 2026Q2: 20,064,545 shares; 2026Q3: 20,064,545 shares 20,064,545 $48.6M 0.49% 0 2026-11-13, 13D/A : 28,742,212 shares, 30.5% of the class, 13D/A filed 2026-11-17 Timeline SPRY ARS PHARMACEUTICALS INC More: the full row for ARS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,860,977 shares; 2025Q1: 10,860,977 shares; 2025Q2: 10,860,977 shares; 2025Q3: 10,860,977 shares; 2025Q4: 10,860,977 shares; 2026Q1: 10,860,977 shares; 2026Q2: 10,860,977 shares; 2026Q3: 10,860,977 shares 10,860,977 $46.8M 0.47% 0 Timeline ABOS ACUMEN PHARMACEUTICALS INC More: the full row for ACUMEN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 14,932,063 shares; 2025Q1: 14,932,063 shares; 2025Q2: 14,932,063 shares; 2025Q3: 14,932,063 shares; 2025Q4: 14,932,063 shares; 2026Q1: 20,992,669 shares; 2026Q2: 20,992,669 shares; 2026Q3: 20,992,669 shares 20,992,669 $46.6M 0.47% 0 Timeline DBVT DBV TECHNOLOGIES S A More: the full row for DBV TECHNOLOGIES S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,657,644 shares 3,657,644 $43M 0.43% new Timeline AGEN AGENUS INC More: the full row for AGENUS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,122,000 shares 4,122,000 $40.9M 0.41% new Timeline RZLT REZOLUTE INC More: the full row for REZOLUTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,180,000 shares; 2026Q1: 9,180,000 shares; 2026Q2: 9,445,039 shares; 2026Q3: 9,445,039 shares 9,445,039 $39.1M 0.39% 0 Timeline SION SIONNA THERAPEUTICS INC More: the full row for SIONNA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 10,445,322 shares; 2025Q2: 10,445,322 shares; 2025Q3: 10,445,322 shares; 2025Q4: 9,905,045 shares; 2026Q1: 9,905,045 shares; 2026Q2: 9,905,045 shares; 2026Q3: 6,456,234 shares 6,456,234 $34M 0.34% -3,448,811 Timeline SCTX SCRIBE THERAPEUTICS INC More: the full row for SCRIBE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,802,178 shares 1,802,178 $33.2M 0.33% new Timeline IPSC CENTURY THERAPEUTICS INC More: the full row for CENTURY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 17,754,430 shares; 2026Q2: 17,754,430 shares; 2026Q3: 17,754,430 shares 17,754,430 $30.4M 0.3% 0 Timeline EVMN EVOMMUNE INC More: the full row for EVOMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,458,770 shares; 2026Q1: 3,494,638 shares; 2026Q2: 3,494,638 shares; 2026Q3: 3,494,638 shares 3,494,638 $28.9M 0.29% 0 2026-11-06, 13D/A : 3,494,638 shares, 8.5% of the class, 13D/A filed 2026-11-10 Timeline KRSA KORSANA BIOSCIENCES INC More: the full row for KORSANA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 892,743 shares 892,743 $28.6M 0.29% new Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,507,844 shares; 2026Q1: 1,507,844 shares; 2026Q2: 1,507,844 shares; 2026Q3: 3,014,183 shares 3,014,183 $28.5M 0.29% +1,506,339 Timeline NKTX NKARTA INC More: the full row for NKARTA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,805,129 shares; 2025Q1: 10,805,129 shares; 2025Q2: 10,805,129 shares; 2025Q3: 10,805,129 shares; 2025Q4: 10,805,129 shares; 2026Q1: 10,805,129 shares; 2026Q2: 10,805,129 shares; 2026Q3: 10,805,129 shares 10,805,129 $28.3M 0.28% 0 Timeline CCCC C4 THERAPEUTICS INC More: the full row for C4 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,878,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,000,000 shares; 2026Q1: 8,000,000 shares; 2026Q2: 8,000,000 shares; 2026Q3: 8,194,779 shares 8,194,779 $27.3M 0.27% +194,779 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,062,326 shares; 2025Q3: 1,062,326 shares; 2025Q4: 3,671,083 shares; 2026Q1: 3,671,083 shares; 2026Q2: 3,671,083 shares; 2026Q3: 1,835,542 shares 1,835,542 $25.8M 0.26% -1,835,541 Timeline PRLD PRELUDE THERAPEUTICS INC More: the full row for PRELUDE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,475,882 shares; 2026Q3: 6,475,882 shares 6,475,882 $25.3M 0.25% 0 Timeline ACRV ACRIVON THERAPEUTICS INC More: the full row for ACRIVON THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,340,508 shares; 2025Q1: 8,340,508 shares; 2025Q2: 8,340,508 shares; 2025Q3: 8,340,508 shares; 2025Q4: 8,340,508 shares; 2026Q1: 8,340,508 shares; 2026Q2: 12,229,396 shares; 2026Q3: 12,229,396 shares 12,229,396 $25.1M 0.25% 0 Timeline ASMB ASSEMBLY BIOSCIENCES INC More: the full row for ASSEMBLY BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,020,410 shares; 2025Q4: 1,020,410 shares; 2026Q1: 1,020,410 shares; 2026Q2: 1,020,410 shares; 2026Q3: 1,020,410 shares 1,020,410 $24M 0.24% 0 Timeline EDIT EDITAS MEDICINE INC More: the full row for EDITAS MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,889,000 shares; 2026Q3: 8,889,000 shares 8,889,000 $22.8M 0.23% 0 Timeline QTTB Q32 BIO INC More: the full row for Q32 BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,332,457 shares; 2026Q3: 2,332,457 shares 2,332,457 $19.3M 0.19% 0 Timeline AVR ANTERIS TECHNOLOGIES GLOBAL More: the full row for ANTERIS TECHNOLOGIES GLOBAL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares; 2026Q2: 3,000,000 shares; 2026Q3: 2,474,076 shares 2,474,076 $19.2M 0.19% -525,924 Timeline ETRA ELECTRA THERAPEUTICS INC More: the full row for ELECTRA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,692,965 shares 1,692,965 $19M 0.19% new Timeline ALT ALTIMMUNE INC More: the full row for ALTIMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,500,000 shares; 2026Q3: 6,500,000 shares 6,500,000 $18.6M 0.19% 0 Timeline BNTC BENITEC BIOPHARMA INC More: the full row for BENITEC BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,850,000 shares; 2026Q1: 1,850,000 shares; 2026Q2: 1,850,000 shares; 2026Q3: 1,850,000 shares 1,850,000 $18.5M 0.19% 0 Timeline ALXO ALX ONCOLOGY HLDGS INC More: the full row for ALX ONCOLOGY HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 13,011,849 shares; 2026Q2: 13,011,849 shares; 2026Q3: 13,011,849 shares 13,011,849 $18.1M 0.18% 0 Timeline SGMT SAGIMET BIOSCIENCES INC More: the full row for SAGIMET BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,800,000 shares 1,800,000 $17.8M 0.18% new Timeline LXEO LEXEO THERAPEUTICS INC More: the full row for LEXEO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 546,554 shares; 2025Q1: 546,554 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,000,000 shares; 2026Q1: 5,000,000 shares; 2026Q2: 5,000,000 shares; 2026Q3: 5,000,000 shares 5,000,000 $16.9M 0.17% 0 Timeline LENZ LENZ THERAPEUTICS INC More: the full row for LENZ THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,178,823 shares; 2025Q1: 4,178,823 shares; 2025Q2: 4,178,823 shares; 2025Q3: 4,178,823 shares; 2025Q4: 4,178,823 shares; 2026Q1: 4,178,823 shares; 2026Q2: 4,178,823 shares; 2026Q3: 4,178,823 shares 4,178,823 $16M 0.16% 0 2026-10-29, 13D/A : 70,533 shares, 0.2% of the class, 13D/A filed 2026-11-02 Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,500,000 shares; 2026Q3: 2,500,000 shares 2,500,000 $15.7M 0.16% 0 Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 967,000 shares; 2025Q1: 967,000 shares; 2025Q2: 932,973 shares; 2025Q3: 662,968 shares; 2025Q4: 662,968 shares; 2026Q1: 662,968 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $15.3M 0.15% 0 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 6,970,000 shares 6,970,000 $14.3M 0.14% new Timeline ENTX ENTERA BIO LTD More: the full row for ENTERA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,901,960 shares 4,901,960 $14.3M 0.14% new Timeline SPTX SEAPORT THERAPEUTICS INC More: the full row for SEAPORT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 700,000 shares; 2026Q3: 700,000 shares 700,000 $14.1M 0.14% 0 Timeline SABS SAB BIOTHERAPEUTICS INC More: the full row for SAB BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,401,500 shares; 2025Q4: 4,401,500 shares; 2026Q1: 4,401,500 shares; 2026Q2: 4,401,500 shares; 2026Q3: 4,401,500 shares 4,401,500 $14M 0.14% 0 Timeline OVID OVID THERAPEUTICS INC More: the full row for OVID THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,714,000 shares; 2026Q1: 10,714,000 shares; 2026Q2: 10,500,968 shares; 2026Q3: 5,598,200 shares 5,598,200 $13.9M 0.14% -4,902,768 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 318,554 shares; 2026Q2: 318,554 shares; 2026Q3: 159,278 shares 159,278 $13.6M 0.14% -159,276 Timeline HLXC HELIX ACQUISITION CORP III More: the full row for HELIX ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,250,000 shares; 2026Q2: 1,250,000 shares; 2026Q3: 1,250,000 shares 1,250,000 $13.3M 0.13% 0 Timeline DRUG BRIGHT MINDS BIOSCIENCES INC More: the full row for BRIGHT MINDS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 460,829 shares; 2025Q1: 206,427 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 265,000 shares; 2026Q2: 265,000 shares; 2026Q3: 265,000 shares 265,000 $13.2M 0.13% 0 Timeline CRBP CORBUS PHARMACEUTICALS HLDGS More: the full row for CORBUS PHARMACEUTICALS HLDGS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,914,788 shares 1,914,788 $13.1M 0.13% new Timeline BRVE BRAVEHEART BIO INC More: the full row for BRAVEHEART BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 565,000 shares 565,000 $11.4M 0.11% new Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,998,333 shares; 2026Q2: 3,998,333 shares; 2026Q3: 3,998,333 shares 3,998,333 $10.9M 0.11% 0 Timeline PALI PALISADE BIO INC More: the full row for PALISADE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,124,116 shares; 2026Q1: 7,124,116 shares; 2026Q2: 7,124,116 shares; 2026Q3: 7,124,116 shares 7,124,116 $9.62M 0.1% 0 Timeline INO INOVIO PHARMACEUTICALS INC More: the full row for INOVIO PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,220,384 shares 7,220,384 $8.81M 0.09% new Timeline MGNX MACROGENICS INC More: the full row for MACROGENICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,864,176 shares; 2026Q2: 1,864,176 shares; 2026Q3: 1,864,176 shares 1,864,176 $7.2M 0.07% 0 Timeline RANI RANI THERAPEUTICS HLDGS INC More: the full row for RANI THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,500,000 shares; 2026Q1: 8,500,000 shares; 2026Q2: 8,500,000 shares; 2026Q3: 8,500,000 shares 8,500,000 $6.72M 0.07% 0 Timeline ACET ADICET BIO INC More: the full row for ADICET BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 948,249 shares; 2026Q1: 1,182,624 shares; 2026Q2: 932,624 shares; 2026Q3: 932,624 shares 932,624 $6.66M 0.07% 0 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $6.25M 0.06% new Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 722,020 shares; 2026Q3: 205,060 shares 205,060 $6.1M 0.06% -516,960 Timeline JATT JATT II ACQUISITION CORP More: the full row for JATT II ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000 $5.62M 0.06% 0 Timeline JTTT JATT III ACQUISITION CORP More: the full row for JATT III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000 $4.96M 0.05% new Timeline NAMSW NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 333,333 shares; 2025Q1: 333,333 shares; 2025Q2: 333,333 shares; 2025Q3: 333,333 shares; 2025Q4: 333,333 shares; 2026Q1: 333,333 shares; 2026Q2: 333,333 shares; 2026Q3: 333,333 shares 333,333 $4.22M 0.04% 0 Timeline AMAN AMANAT ACQUISITION CORP More: the full row for AMANAT ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,000 shares; 2026Q3: 375,000 shares 375,000 $4M 0.04% 0 Timeline EQ EQUILLIUM INC More: the full row for EQUILLIUM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,096,336 shares; 2026Q2: 3,096,336 shares; 2026Q3: 2,317,741 shares 2,317,741 $3.77M 0.04% -778,595 Timeline STRO SUTRO BIOPHARMA INC More: the full row for SUTRO BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 715,307 shares; 2026Q2: not reported; 2026Q3: 210,934 shares 210,934 $3.4M 0.03% new Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 73,607 shares 73,607 $1.91M 0.02% new Timeline PTN PALATIN TECHNOLOGIES INC More: the full row for PALATIN TECHNOLOGIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares; 2026Q1: 70,000 shares; 2026Q2: 62,124 shares; 2026Q3: 62,124 shares 62,124 $551K 0.01% 0 Timeline